Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ALFACELL CORP | 540,000 | reported | 23 Jul 2012 | tx 11+1,203,750−5,000 |
| EPICEPT CORP | 21,699 | reported | 08 Jan 2015 | tx 13+216,713 |
| CHAMPIONS ONCOLOGY, INC. | 21,216 | reported | 05 Nov 2025 | tx 29+4,917,412−238,662 |
| Business Outsourcing Service, Inc. | 20,450 | reported | 20 Dec 2023 | tx 13+189,026 |
| IMCLONE SYSTEMS INC/DE | 18,750 | reported | 18 Jan 2006 | tx 10+128,434 |
| ZILA INC | 16,000 | reported | 09 Jan 2007 | tx 3+46,000 |
| Advaxis, Inc. | 2,342 | reported | 19 Jan 2023 | tx 21+320,898−22,808 |
| Ayala Pharmaceuticals, Inc. | 0 | reported | 19 Jan 2023 | tx 13+25,250−25,250 |
| KV PHARMACEUTICAL CO /DE/ | 0 | reported | 16 Sept 2013 | tx 10+65,000−58,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Nov 2025 | GRANT_AWARD | CHAMPIONS ONCOLOGY, INC. | 21,216 | 6.80 USD | deriv |
| 12 Nov 2024 | GRANT_AWARD | CHAMPIONS ONCOLOGY, INC. | 21,880 | 4.64 USD | deriv |
| 20 Dec 2023 | GRANT_AWARD | Business Outsourcing Service, Inc. | 20,450 | 0.00 USD | deriv |
| 03 Nov 2023 | GRANT_AWARD | CHAMPIONS ONCOLOGY, INC. | 15,495 | 5.51 USD | deriv |
| 01 Nov 2022 | GRANT_AWARD | CHAMPIONS ONCOLOGY, INC. | 11,480 | 7.00 USD | deriv |
| 19 Jan 2023 | GRANT_AWARD | Advaxis, Inc. | 46 | — | |
| 19 Jan 2023 | GRANT_AWARD | Advaxis, Inc. | 2,342 | — | deriv |
| 19 Jan 2023 | GRANT_AWARD | Advaxis, Inc. | 2,342 | — | deriv |
| 19 Jan 2023 | OTHER | Ayala Pharmaceuticals, Inc. | 250 | — | |
| 19 Jan 2023 | OTHER | Ayala Pharmaceuticals, Inc. | 12,500 | — | deriv |
| 19 Jan 2023 | OTHER | Ayala Pharmaceuticals, Inc. | 12,500 | — | deriv |
| 23 Dec 2022 | GRANT_AWARD | Business Outsourcing Service, Inc. | 20,450 | 0.00 USD | deriv |
| 12 Oct 2022 | EXERCISE | CHAMPIONS ONCOLOGY, INC. | 8,333 | 3.21 USD | |
| 12 Oct 2022 | TAX_WITHHOLDING | CHAMPIONS ONCOLOGY, INC. | 3,562 | 7.51 USD | |
| 12 Oct 2022 | EXERCISE | CHAMPIONS ONCOLOGY, INC. | 8,333 | 0.00 USD | deriv |
| 13 Jun 2022 | GRANT_AWARD | Ayala Pharmaceuticals, Inc. | 12,500 | 0.00 USD | deriv |
| 16 Dec 2021 | GRANT_AWARD | Business Outsourcing Service, Inc. | 2,045 | 0.00 USD | deriv |
| 05 Nov 2021 | GRANT_AWARD | CHAMPIONS ONCOLOGY, INC. | 8,045 | 10.10 USD | deriv |
| 15 Oct 2021 | EXERCISE | CHAMPIONS ONCOLOGY, INC. | 16,667 | 1.59 USD | |
| 15 Oct 2021 | TAX_WITHHOLDING | CHAMPIONS ONCOLOGY, INC. | 2,629 | 10.08 USD | |
| 15 Oct 2021 | GRANT_AWARD | CHAMPIONS ONCOLOGY, INC. | 16,667 | 0.00 USD | deriv |
| 10 Jun 2021 | GRANT_AWARD | Ayala Pharmaceuticals, Inc. | 12,500 | 0.00 USD | deriv |
| 14 Aug 2020 | PURCHASE | Ayala Pharmaceuticals, Inc. | 5 | 11.07 USD | |
| 11 Sept 2020 | PURCHASE | Ayala Pharmaceuticals, Inc. | 10 | 10.07 USD | |
| 08 May 2020 | PURCHASE | Ayala Pharmaceuticals, Inc. | 200 | 15.27 USD |
1 purchase reported after at least 12 months of silence — most recent on 07 May 2020.